ICPT - Intercept Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.69B
Enterprise Value 32.62B
Trailing P/E N/A
Forward P/E 1-12.70
PEG Ratio (5 yr expected) 11.13
Price/Sales (ttm)14.95
Price/Book (mrq)140.57
Enterprise Value/Revenue 314.59
Enterprise Value/EBITDA 6-9.34

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018


Profit Margin -171.99%
Operating Margin (ttm)-158.78%

Management Effectiveness

Return on Assets (ttm)-35.92%
Return on Equity (ttm)-1,741.42%

Income Statement

Revenue (ttm)179.8M
Revenue Per Share (ttm)6.32
Quarterly Revenue Growth (yoy)41.40%
Gross Profit (ttm)177.28M
EBITDA -280.91M
Net Income Avi to Common (ttm)-309.24M
Diluted EPS (ttm)-10.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)436.16M
Total Cash Per Share (mrq)14.69
Total Debt (mrq)371.25M
Total Debt/Equity (mrq)1,940.67
Current Ratio (mrq)4.22
Book Value Per Share (mrq)0.64

Cash Flow Statement

Operating Cash Flow (ttm)-240.71M
Levered Free Cash Flow (ttm)-130.31M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.74
52-Week Change 331.53%
S&P500 52-Week Change 310.18%
52 Week High 3133.74
52 Week Low 364.50
50-Day Moving Average 3106.86
200-Day Moving Average 3105.77

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 31.26M
Shares Outstanding 529.69M
Float 22.82M
% Held by Insiders 124.22%
% Held by Institutions 172.67%
Shares Short (Mar 29, 2019) 44.4M
Short Ratio (Mar 29, 2019) 45.4
Short % of Float (Mar 29, 2019) 424.55%
Short % of Shares Outstanding (Mar 29, 2019) 414.83%
Shares Short (prior month Feb 28, 2019) 44.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A